Brief: Hyloris Announces US FDA Approval For Podofilox Gel
04/12/2023 06:20
Dec 4 (Reuters) - Hyloris Pharmaceuticals SA HYL.BR :
* HYLORIS ANNOUNCES US FDA APPROVAL FOR PODOFILOX GEL
* US COMMERCIALIZATION BY PARTNER PADAGIS TO START IN
DECEMBER
2023
Source text for Eikon: urn:newsml:reuters.com:*:nGNX981HBB
Further company coverage: HYL.BR
(Gdansk Newsroom)
((gdansknewsroom@thomsonreuters.com; + 48 58 7785110;))
Recent news on Hyloris Pharmaceuticals SA
See all newsEurope Research Roundup: Akzo Nobel, MTU Aero Engines, Symrise
Brief: Hyloris Pharmaceuticals Says It Obtains Exclusive License Rights In Europe & Turkey From Arbormed For Its Wilson's Disease Therapy
Brief: Hyloris Announces Partnership With Rosemont Pharmaceuticals For Atomoxetine Oral Solution In The U.S.
Brief: Hyloris Announces Positive Study Results For Dofetilide IV
Brief: Hyloris Pharmaceuticals SA Says HY 2024 Revenues (Royalties And Milestones) Increased To EUR 4,2 Million